Cargando…

Editorial: New strategies to tackle chemoresistance in cancer

Detalles Bibliográficos
Autores principales:	De Marco, Carmela, Sonego, Maura, Battaglia, Anna Martina, Viglietto, Giuseppe, Biamonte, Flavia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641286/ https://www.ncbi.nlm.nih.gov/pubmed/36387111 http://dx.doi.org/10.3389/fonc.2022.1062921

Ejemplares similares

Editorial: Strategies in overcoming the chemoresistance in colorectal cancer
por: Vodenkova, Sona, et al.
Publicado: (2023)

Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways
por: Mountzios, Giannis, et al.
Publicado: (2022)

Editorial: Drug resistance in breast cancer – mechanisms and approaches to overcome chemoresistance
por: Raman, Dayanidhi, et al.
Publicado: (2023)

Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells
por: Battaglia, Anna Martina, et al.
Publicado: (2022)

Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies
por: Cao, Jun, et al.
Publicado: (2021)

Ferritin heavy subunit enhances apoptosis of non-small cell lung cancer cells through modulation of miR-125b/p53 axis
por: Biamonte, Flavia, et al.
Publicado: (2018)

Editorial: The role of transcription factors, stem cell markers and epigenetics contributing to chemoresistance in brain cancers
por: Castresana, Javier S., et al.
Publicado: (2023)

Targeting Lysosomes in Cancer as Promising Strategy to Overcome Chemoresistance—A Mini Review
por: Geisslinger, Franz, et al.
Publicado: (2020)

Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies
por: Cao, Jun, et al.
Publicado: (2021)

The MicroRNA-Based Strategies to Combat Cancer Chemoresistance via Regulating Autophagy
por: Lei, Yuhe, et al.
Publicado: (2022)

Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies
por: Chakrabarty, Anindita, et al.
Publicado: (2021)

MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer
por: Biamonte, Flavia, et al.
Publicado: (2019)

Drosophila as a toolkit to tackle cancer and its metabolism
por: Jiang, Hui, et al.
Publicado: (2022)

FtH-Mediated ROS Dysregulation Promotes CXCL12/CXCR4 Axis Activation and EMT-Like Trans-Differentiation in Erythroleukemia K562 Cells
por: Chirillo, Roberta, et al.
Publicado: (2020)

The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer
por: Liu, Chang, et al.
Publicado: (2021)

Editorial: Novel diagnostic and therapeutic strategies in the management of cerebral gliomas, Volume II
por: Bosio, Alberto, et al.
Publicado: (2023)

Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment
por: Gaggianesi, Miriam, et al.
Publicado: (2021)

Editorial: Targeting Pancreatic Cancer: Strategies and Hopes
por: Manu, Kanjoormana Aryan, et al.
Publicado: (2022)

The Unpluggable in Pursuit of the Undruggable: Tackling the Dark Matter of the Cancer Therapeutics Universe
por: Epstein, Richard J.
Publicado: (2013)

Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer
por: Mercogliano, María Florencia, et al.
Publicado: (2020)

Breast cancer: miRNAs monitoring chemoresistance and systemic therapy
por: Singh, Shivam, et al.
Publicado: (2023)

microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview
por: Gabra, Martino Marco, et al.
Publicado: (2017)

Editorial: Molecular Targets and Therapeutic Strategies in Gynecological Cancers
por: Lu, Ziwen, et al.
Publicado: (2022)

Editorial: Emerging strategies for cancer therapy targeting ferroptosis
por: Li, Manshan, et al.
Publicado: (2023)

Ferritin Heavy Subunit Silencing Blocks the Erythroid Commitment of K562 Cells via miR-150 up-Regulation and GATA-1 Repression
por: Zolea, Fabiana, et al.
Publicado: (2017)

Editorial: New Approaches to Tackle EMT and Fibrosis: From Epigenetics to Nanotechnology
por: Battistelli, Cecilia, et al.
Publicado: (2021)

Editorial: Genomics of Lymphoproliferative Disease
por: Maura, Francesco, et al.
Publicado: (2021)

Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
por: Sridharan, Sangita, et al.
Publicado: (2019)

Hyperglycemia and Chemoresistance in Breast Cancer: From Cellular Mechanisms to Treatment Response
por: Qiu, Jie, et al.
Publicado: (2021)

Chemoresistance Transmission via Exosome-Transferred MMP14 in Pancreatic Cancer
por: Li, Xinyuan, et al.
Publicado: (2022)

Ferroptosis and Cancer: Mitochondria Meet the “Iron Maiden” Cell Death
por: Battaglia, Anna Martina, et al.
Publicado: (2020)

Editorial: Cancer and nutrients: new chemicals, signals, and biomarker-based therapy
por: Qin, Xian-Yang, et al.
Publicado: (2023)

Editorial: Cholangiocarcinoma a New Multimodality Approach
por: Bronte, Fabrizio, et al.
Publicado: (2022)

Editorial: Gastrointestinal Tumor Heterogeneity and Related Anti-Cancer Strategies
por: Liao, Rui, et al.
Publicado: (2022)

Editorial: The Microenvironment in Pancreatic Cancer and Therapeutic Strategies Targeting Microenvironment
por: Duan, Wanxing, et al.
Publicado: (2022)

Editorial: Microbiota and metabolites in cancer immunotherapy
por: Roviello, Giandomenico, et al.
Publicado: (2022)

Chemoresistance in H-Ferritin Silenced Cells: The Role of NF-κB
por: Aversa, Ilenia, et al.
Publicado: (2018)

A new role for IDH1 in the control of ovarian cancer cells metabolism and senescence
por: Sonego, Maura, et al.
Publicado: (2020)

Phenotypic Basis for Matrix Stiffness-Dependent Chemoresistance of Breast Cancer Cells to Doxorubicin
por: Joyce, M. Hunter, et al.
Publicado: (2018)

CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target
por: Feng, Xiaojie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_slcq5v8prs138ji4q5a84hb7ol